this is hero image

Long term is life changing.

Eversense gives you the reliable data you need, so you can focus on managing your diabetes and your daily life. See what real people have to say.

Real Impact, Proven Results.

By reducing the burden of wearing a CGM device, those who have switched to Eversense E3 have gained more confidence and control over their diabetes self-management.

85%

Reported improved confidence over control of their diabetes1

86%

Reported less day-to-day burden1

80%

Were more motivated to keep up with diabetes management1

84%

Of users would choose to be inserted again1

5 simple questions to see if you’re
ready for a long-term CGM.

1. Does the adhesive on your current CGM irritate your skin?

 

2. Tired of false lows/false readings or gaps in data?

 

3. Want to occasionally remove your CGM without wasting a sensor?

 

4. Do your CGM alerts sometimes disrupt those around you?

 

5. Would you prefer only 1 sensor change a year?

 

If you answered yes to any of these questions, then Eversense may be the ideal CGM for you.

this is 50 | 50 image

Looking for more reasons to switch?

Here are a few ways Eversense outlasts and outperforms short-term CGMs. 

Eversense 3654
Short-Term Traditional CGMs2-3
Sensor life
12 months
10-14 days
Sensor changes per year
1
26-36
Day 1 warmup periods
1
26-36
Insertion by trained professional
Yes
No
Transmitter can be removed and put back on without wasting a sensor*
Yes*
No
On-body alerts
Yes
No
Silicone-based fresh daily adhesive for comfort2
Yes
No
Dianne

“Since using Eversense E3, I worry much less about having severe hypoglycemia. I used to worry about it every day because I knew one was coming.”

Chris

“Eversense helps me with diabetes management in general because I wear my CGM more… My time in-range has gone up, my A1C has gone down, and my quality of life has improved.”

Matt

“The fact that I can be [presenting in a meeting] and have the on-body vibe alerts tell me if I’m going low or high and be able to respond without broadcasting it has been really helpful and really freeing for me.”

Paul

“I do a lot of work in the outdoors, where a traditional CGM may not survive. It’s nice to know that I can remove the transmitter to get through the rougher terrain and put it right back on when I’m done.”

Mary

“I trust what my Eversense tells me. To have accurate numbers in my life means peace of mind. I can trust the system, and I don’t have to second-guess everything.”

Join us.

Connect with people within the Eversense community, dive deeper into their stories and access additional resources around long-term diabetes management.

COMMUNITY
this is 50 | 50 image

Want to see if you
qualify?

Our short quiz will ask about your insurance coverage, your insulin usage, and what benefits you’re looking for in a CGM.

If you’re ready, click below and let’s see if Eversense 365 is right for you.

* There is no glucose data generated when the transmitter is removed

1. Barnard et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor. Journal of Diabetes Science and Technology 2018, Vol. 12(3) 634–638.
2. Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24
3. Dexcom (2024) G7 User Guide AW00078-10 Rev 003 MT-00078-10
4. Senseonics. (2024) Eversense E3 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001 Rev A
5. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206
6. Senseonics. (2023) Eversense E3 Continuous Glucose Monitoring System User Guide. LBL-6002-01-001_Rev C

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0061